Review Article
Role of Garlic Usage in Cardiovascular Disease Prevention: An Evidence-Based Approach
Table 3
Effect of garlic on cardiovascular disease.
| Study | Type | Target | Duration of treatment | Dose | Route | Case/control | Outcome |
| Bordia et al., (1998) [63] | Placebo control trial | Coronary artery disease patients | 3 months | 1 gm garlic (capsules) | Oral | 30/30 | Dec T. chol and TG, increase HDL level, and no effect on fibrinogen and glucose level |
| Sobenin et al., (2010) [71] | Randomized control trial | Coronary artery disease patients | 1 year | Time-released garlic powder | Oral | 26/25 | Dec LDL—32.9 mg/dL in males, 27.3 mg/dL in females |
|
|
T. chol: total cholesterol, HDL: high-density lipoprotein, TG triglyceride, LDL: low-density lipoprotein.
|